Newsletter
VEGF Inhibitor vs Vitrectomy for Diabetic Retinopathy, FFR-Based PCI, USPSTF Guideline on HBV Screening, and more

JAMA Editor’s Summary

VEGF Inhibitor vs Vitrectomy for Diabetic Retinopathy, FFR-Based PCI, USPSTF Guideline on HBV Screening, and more

Editor's Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the
December 15, 2020
ADVERTISEMENT

Newer →

Digoxin vs Bisoprolol for AFib, Risk of Second Cancer After a First Cancer, Review of GERD and more

← Older

Omega-3 Fatty Acids for CVD Prevention, Co-trimaxazole (TMP/SMX) for IPF, Asthma Management Guidelines, and more
Buffer LinkedIn WhatsApp

VEGF Inhibitor vs Vitrectomy for Diabetic Retinopathy, FFR-Based PCI, USPSTF Guideline on HBV Screening, and more

Editor’s Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the December 15, 2020 issue

ADVERTISEMENT
ADVERTISEMENT

Listen on your favorite player

New to Podcasts? It's easy to get started!

You may also like

The Latest Health Podcasts. Delivered to Your Inbox.

Join Our Newsletter

We gratefully acknowledge the many organizations that have generously supported our podcasts and platform.

Silver Sponsors

Bronze Sponsors

Event and Media Partners

Buffer LinkedIn WhatsApp
00:00
00:00